Published June 21, 2019 This content is archived.
Hauptman-Woodward Medical Research Institute (HWI) announced that at its recent annual members meeting five directors were elected or re-elected to three year terms on the organization’s Board of Directors.
Elected to a first term were:
Re-elected to an additional three-year term were:
In addition, the Board elected its officers for 2019-20:
“A key to any non-profit’s success is a diverse, skilled, and engaged board,” Horn said. “The team we have assembled, as typified by our new and renewing members, checks every one of those boxes. I am humbled and delighted to serve with them.”
“HWI is a remarkable research center where scientists work on therapies and cures from which our children and grandchildren will benefit,” Bell added. “It is also a premier independent medical innovator you would expect to locate in other major American cities ten times our size, but it’s in Buffalo; and the best is yet to come: Building on Nobel Prize winner Herbert Hauptman’s work, HWI aspires to become the Buffalo Niagara Medical Campus’ ideas and solutions generator.”
Hauptman-Woodward Medical Research Institute’s work improves human health by studying the causes of diseases, as well as potential therapies, at their basic molecular level. HWI is a founding member of the Buffalo Niagara Medical Campus, and resides in a state-of-the-art research facility at 700 Ellicott Street. For more information, visit hwi.buffalo.edu.
